Rational pharmacotherapy of uterine fibroids in their reproductive years

Cover Page

Abstract


The article presents comparative research data to improve the reproductive health of women with uterine fibroids with antiprogestins, selective progesterone receptor modulators (SPRM) and gonadotropin-releasing hormone (GnRH), depending on the size, location and clinical manifestations of leiomyoma. To evaluate the effectiveness of therapy was carried out clinical and statistical analysis of the survey results in patients with uterine myoma patients and analyzed the results of laboratory and instrumental methods of examination in dynamics during treatment and for 6 months after graduation.

About the authors

T V Galina

Peoples’ Friendship University of Russia

Email: tatyana.galina1@mail.ru

Y O Stykin

Peoples’ Friendship University of Russia

Email: stikyar@inbox.ru

N P Ermolova

Peoples’ Friendship University of Russia

Email: stikyar@inbox.ru

T P Golikova

Peoples’ Friendship University of Russia

Email: naramm@mail.ru

References

Statistics

Views

Abstract - 248

PDF (Russian) - 149

Cited-By



Copyright (c) 2016 Галина Т.В., Стыкин Я.О., Ермолова Н.П., Голикова Т.П.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies